Case Report: Response of cutaneous lupus lesions in SLE to interferon receptor blockade parallels reduction of interferon score in blood

Cutaneous lupus erythematosus (CLE), the main manifestation of systemic lupus erythematosus (SLE), is driven by type I interferons (IFNs) and often only partially responds to conventional therapies. Treatment of seven SLE patients with the monoclonal antibody anifrolumab induced fast and sustained r...

Descripción completa

Detalles Bibliográficos
Autores principales: Günther, Claudia, Wolf, Christine, Fennen, Louisa, Rösing, Sarah, Beissert, Stefan, Aringer, Martin, Lee-Kirsch, Min Ae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551165/
https://www.ncbi.nlm.nih.gov/pubmed/37809086
http://dx.doi.org/10.3389/fimmu.2023.1253279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551165/
https://www.ncbi.nlm.nih.gov/pubmed/37809086
http://dx.doi.org/10.3389/fimmu.2023.1253279

Ejemplares similares